PATENT CLAIM ANALYSIS

Application Number: 15920005
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-04
Patent Classification: ["424", "450000"]

Abstract:
A method for protecting corneal endothelial cells from the impact caused by an eye surgery is disclosed. The ophthalmic composition is administered to a patient's eye continuously for at least five days before an eye surgery for reducing the impact to the corneal endothelial cells caused by the eye surgery. The ophthalmic composition comprises an ascorbic acid and a pharmaceutically acceptable ophthalmic carrier.

Claim (Index 2):
The method as claimed in  claim 1 , wherein the concentration of the ascorbic acid in the ophthalmic composition is 10 mg/cc to 60 mg/cc.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.675
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11548076', '13918963', '13305391', '12802663', '11594428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7280113775189269
- 35 USC 102 Novelty (BERT): 0.5039372567501905
- Combined Prediction Score: 0.7056039654420533
- Mean Citation Score: 185.348886
- Max Citation Score: 195.6228
- Similarity Product: 115.8991575858593

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test